'Checa tu Salud': the CROC brings biometric AI to 250,000 Mexican workers in 30 seconds

By Momentum IA · June 28, 2026.

The Revolutionary Confederation of Workers and Peasants (CROC) has launched in Cancún a digital platform called 'Checa tu Salud' that uses artificial intelligence and biometric scanning to diagnose risk factors in approximately 30 seconds. The system extracts data on muscle mass, blood pressure, heart and respiratory rate, and stress variability without the need for hospital equipment. The stated goal is to reach 250,000 affiliated workers in the state of Quintana Roo, deploying the service permanently and free of charge directly at workplaces. Claudia Arres Paxtian, head of health for this union platform at the national level, was the one who presented the initiative.

The epidemiological context that justifies the project is no small matter. According to IMSS statistics cited in the presentation, 72% of the Mexican population has some degree of obesity, which quadruples their susceptibility to developing diabetes and hypertension. More than half of hospitalized patients present complications arising from these conditions. Added to this picture is that the cost of private consultations and medications grew 4% in Mexico in the past year alone. The pressure on the public health system, combined with the economic barriers to the private system, leaves millions of workers in no man's land: with neither the time nor the money for a regular preventive checkup.

Here lies the real interest of this news, beyond the technological gadget. It is not a hospital or a major insurer adopting cutting-edge AI: it is a union —a structure historically associated with labor negotiation, not health innovation— that brings the tool directly to the factory, the office, the workshop. That changes the vector of access. The person who does not book an appointment because they cannot afford to lose half a day of work, or because the nearest health center has a waiting list, receives in 30 seconds, in their own work environment, a first reading of their physical state. It is prevention where there was none before.

Our reading is that this type of initiative represents something structurally important, though still embryonic: the decentralization of the first health filter. Historically, early diagnosis has been a privilege of those with fluid access to the medical system. AI does not eliminate that inequality in one stroke, but it can shift the point of entry. A worker who would never have gone to the doctor on their own initiative receives an alert about their blood pressure or their stress level and, with that information, can —or can be guided to— take the next step. The early detection of hypertension or prediabetes has an impact on mortality and quality of life that no hospital can match once the disease is established.

That said, it is fair to be honest about what this system is not. The program's own director acknowledged it explicitly: the platform does not replace an in-depth assessment by a doctor. A 30-second biometric scan can guide, not diagnose with clinical certainty. The questions that remain open are relevant: What happens to the biometric data collected and who manages it? What is the system's rate of false positives or negatives, and are clinical validation studies available? Is there a clear referral protocol when the system detects anomalies, or is the worker left alone with a result on a screen without follow-up? These are not objections to dismiss the tool, but minimum conditions for its promise to materialize without causing harm —from false reassurance to unjustified alarms with real psychological impact.

In industry terms, what this Mexican case illustrates is an accelerating global trend: occupational health as a vector for the mass adoption of health AI. Companies and unions have their own incentives —reducing absenteeism, improving productivity, covering liabilities— to invest in prevention tools that the public system cannot provide with the necessary frequency. In markets with saturated or unevenly distributed health infrastructure, as in much of Latin America, that logic becomes even more powerful. It is no coincidence that the experiment is taking place in Quintana Roo, a state whose economy rests on tourism and service work: sectors with high turnover, intense workdays, and workers frequently far from their usual support networks.

The 'Checa tu Salud' program is not going to cure diabetes in Mexico. But if it manages to give tens of thousands of people who would never have walked into a consultation a first useful signal about their bodies, it will have justified its existence. The long term that Momentum IA champions —a society where AI helps eradicate chronic diseases and prolong health— does not arrive all at once with a great discovery. It also arrives in increments like this one: a union tool in Cancún that turns 30 seconds in front of a screen into the first link in the preventive chain for those who never had access to it before.